262 related articles for article (PubMed ID: 12208866)
1. The role of prostaglandin E2 receptors in the pathogenesis of rheumatoid arthritis.
McCoy JM; Wicks JR; Audoly LP
J Clin Invest; 2002 Sep; 110(5):651-8. PubMed ID: 12208866
[TBL] [Abstract][Full Text] [Related]
2. Dominant role of prostaglandin E2 EP4 receptor in furosemide-induced salt-losing tubulopathy: a model for hyperprostaglandin E syndrome/antenatal Bartter syndrome.
Nüsing RM; Treude A; Weissenberger C; Jensen B; Bek M; Wagner C; Narumiya S; Seyberth HW
J Am Soc Nephrol; 2005 Aug; 16(8):2354-62. PubMed ID: 15976003
[TBL] [Abstract][Full Text] [Related]
3. Prostacyclin-IP signaling and prostaglandin E2-EP2/EP4 signaling both mediate joint inflammation in mouse collagen-induced arthritis.
Honda T; Segi-Nishida E; Miyachi Y; Narumiya S
J Exp Med; 2006 Feb; 203(2):325-35. PubMed ID: 16446378
[TBL] [Abstract][Full Text] [Related]
4. Protection against cartilage and bone destruction by systemic interleukin-4 treatment in established murine type II collagen-induced arthritis.
Joosten LA; Lubberts E; Helsen MM; Saxne T; Coenen-de Roo CJ; Heinegård D; van den Berg WB
Arthritis Res; 1999; 1(1):81-91. PubMed ID: 11056663
[TBL] [Abstract][Full Text] [Related]
5. MF498 [N-{[4-(5,9-Diethoxy-6-oxo-6,8-dihydro-7H-pyrrolo[3,4-g]quinolin-7-yl)-3-methylbenzyl]sulfonyl}-2-(2-methoxyphenyl)acetamide], a selective E prostanoid receptor 4 antagonist, relieves joint inflammation and pain in rodent models of rheumatoid and osteoarthritis.
Clark P; Rowland SE; Denis D; Mathieu MC; Stocco R; Poirier H; Burch J; Han Y; Audoly L; Therien AG; Xu D
J Pharmacol Exp Ther; 2008 May; 325(2):425-34. PubMed ID: 18287210
[TBL] [Abstract][Full Text] [Related]
6. Prostaglandin E2 (PGE2) downregulates interleukin (IL)-1alpha-induced IL-6 production via EP2/EP4 subtypes of PGE2 receptors in human periodontal ligament cells.
Noguchi K; Maeda M; Ruwanpura SM; Ishikawa I
Oral Dis; 2005 May; 11(3):157-62. PubMed ID: 15888106
[TBL] [Abstract][Full Text] [Related]
7. E-prostanoid (EP)2/EP4 receptor-dependent maturation of human monocyte-derived dendritic cells and induction of helper T2 polarization.
Kubo S; Takahashi HK; Takei M; Iwagaki H; Yoshino T; Tanaka N; Mori S; Nishibori M
J Pharmacol Exp Ther; 2004 Jun; 309(3):1213-20. PubMed ID: 14872092
[TBL] [Abstract][Full Text] [Related]
8. Pharmacological characterisation of CR6086, a potent prostaglandin E
Caselli G; Bonazzi A; Lanza M; Ferrari F; Maggioni D; Ferioli C; Giambelli R; Comi E; Zerbi S; Perrella M; Letari O; Di Luccio E; Colovic M; Persiani S; Zanelli T; Mennuni L; Piepoli T; Rovati LC
Arthritis Res Ther; 2018 Mar; 20(1):39. PubMed ID: 29490676
[TBL] [Abstract][Full Text] [Related]
9. Involvement of prostaglandin E(2) in interleukin-1alpha-induced parathyroid hormone-related peptide production in synovial fibroblasts of patients with rheumatoid arthritis.
Yoshida T; Sakamoto H; Horiuchi T; Yamamoto S; Suematsu A; Oda H; Koshihara Y
J Clin Endocrinol Metab; 2001 Jul; 86(7):3272-8. PubMed ID: 11443200
[TBL] [Abstract][Full Text] [Related]
10. Effects of PGE2 EP3/EP4 receptors on bladder dysfunction in mice with experimental autoimmune encephalomyelitis.
Xue R; Jia Z; Kong X; Pi G; Ma S; Yang J
Am J Physiol Renal Physiol; 2013 Dec; 305(12):F1656-62. PubMed ID: 24154697
[TBL] [Abstract][Full Text] [Related]
11. Crucial involvement of the EP4 subtype of prostaglandin E receptor in osteoclast formation by proinflammatory cytokines and lipopolysaccharide.
Sakuma Y; Tanaka K; Suda M; Yasoda A; Natsui K; Tanaka I; Ushikubi F; Narumiya S; Segi E; Sugimoto Y; Ichikawa A; Nakao K
J Bone Miner Res; 2000 Feb; 15(2):218-27. PubMed ID: 10703923
[TBL] [Abstract][Full Text] [Related]
12. Impaired adrenocorticotropic hormone response to bacterial endotoxin in mice deficient in prostaglandin E receptor EP1 and EP3 subtypes.
Matsuoka Y; Furuyashiki T; Bito H; Ushikubi F; Tanaka Y; Kobayashi T; Muro S; Satoh N; Kayahara T; Higashi M; Mizoguchi A; Shichi H; Fukuda Y; Nakao K; Narumiya S
Proc Natl Acad Sci U S A; 2003 Apr; 100(7):4132-7. PubMed ID: 12642666
[TBL] [Abstract][Full Text] [Related]
13. Impaired febrile response in mice lacking the prostaglandin E receptor subtype EP3.
Ushikubi F; Segi E; Sugimoto Y; Murata T; Matsuoka T; Kobayashi T; Hizaki H; Tuboi K; Katsuyama M; Ichikawa A; Tanaka T; Yoshida N; Narumiya S
Nature; 1998 Sep; 395(6699):281-4. PubMed ID: 9751056
[TBL] [Abstract][Full Text] [Related]
14. EP4/EP2 receptor-specific prostaglandin E2 regulation of interleukin-6 generation by human HSB.2 early T cells.
Zeng L; An S; Goetzl EJ
J Pharmacol Exp Ther; 1998 Sep; 286(3):1420-6. PubMed ID: 9732406
[TBL] [Abstract][Full Text] [Related]
15. Anorexia and cachexia in prostaglandin EP1 and EP3 subtype receptor knockout mice bearing a tumor with high intrinsic PGE2 production and prostaglandin related cachexia.
Wang W; Andersson M; Lönnroth C; Svanberg E; Lundholm K
J Exp Clin Cancer Res; 2005 Mar; 24(1):99-107. PubMed ID: 15943039
[TBL] [Abstract][Full Text] [Related]
16. Prostaglandin EP2 and EP4 receptors modulate expression of the chemokine CCL2 (MCP-1) in response to LPS-induced renal glomerular inflammation.
Zahner G; Schaper M; Panzer U; Kluger M; Stahl RA; Thaiss F; Schneider A
Biochem J; 2009 Aug; 422(3):563-70. PubMed ID: 19570035
[TBL] [Abstract][Full Text] [Related]
17. Interleukin-1 beta-induced expression of the prostaglandin E-receptor subtype EP3 in U373 astrocytoma cells depends on protein kinase C and nuclear factor-kappaB.
Waschbisch A; Fiebich BL; Akundi RS; Schmitz ML; Hoozemans JJ; Candelario-Jalil E; Virtainen N; Veerhuis R; Slawik H; Yrjänheikki J; Hüll M
J Neurochem; 2006 Feb; 96(3):680-93. PubMed ID: 16405508
[TBL] [Abstract][Full Text] [Related]
18. Prostaglandin E2 promotes wound-induced migration of intestinal subepithelial myofibroblasts via EP2, EP3, and EP4 prostanoid receptor activation.
Iwanaga K; Okada M; Murata T; Hori M; Ozaki H
J Pharmacol Exp Ther; 2012 Mar; 340(3):604-11. PubMed ID: 22138372
[TBL] [Abstract][Full Text] [Related]
19. Prostaglandin E receptor subtypes involved in stimulation of gastroduodenal bicarbonate secretion in rats and mice.
Takeuchi K; Ukawa H; Furukawa O; Kawauchi S; Araki H; Sugimoto Y; Ishikawa A; Ushikubi F; Narumiya S
J Physiol Pharmacol; 1999 Jun; 50(2):155-67. PubMed ID: 10424714
[TBL] [Abstract][Full Text] [Related]
20. Cyclooxygenase-2-dependent prostaglandin (PG) E2 downregulates matrix metalloproteinase-3 production via EP2/EP4 subtypes of PGE2 receptors in human periodontal ligament cells stimulated with interleukin-1alpha.
Yan M; Noguchi K; Ruwanpura SM; Ishikawa I
J Periodontol; 2005 Jun; 76(6):929-35. PubMed ID: 15948687
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
